COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
Overall COLL gets a fundamental rating of 6 out of 10. We evaluated COLL against 195 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are concerns on its financial health. COLL is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
COLL had a positive operating cash flow in the past year.
In multiple years COLL reported negative net income over the last 5 years.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 5.42%, COLL belongs to the best of the industry, outperforming 89.25% of the companies in the same industry.
COLL has a Return On Equity of 37.82%. This is amongst the best in the industry. COLL outperforms 96.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.46%, COLL belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
COLL had an Average Return On Invested Capital over the past 3 years of 8.70%. This is significantly below the industry average of 44.00%.
The last Return On Invested Capital (10.46%) for COLL is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROIC | 10.46% |
ROA(3y)4.14%
ROA(5y)1.83%
ROE(3y)15.68%
ROE(5y)7.1%
ROIC(3y)8.7%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 14.78%, COLL belongs to the best of the industry, outperforming 89.25% of the companies in the same industry.
COLL's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 32.29%, COLL belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
In the last couple of years the Operating Margin of COLL has grown nicely.
COLL's Gross Margin of 62.36% is fine compared to the rest of the industry. COLL outperforms 68.28% of its industry peers.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% |
OM growth 3Y19.53%
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y7.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COLL is still creating some value.
The number of shares outstanding for COLL has been reduced compared to 1 year ago.
The number of shares outstanding for COLL has been reduced compared to 5 years ago.
COLL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.02, we must say that COLL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.02, COLL perfoms like the industry average, outperforming 58.60% of the companies in the same industry.
The Debt to FCF ratio of COLL is 4.51, which is a neutral value as it means it would take COLL, 4.51 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COLL (4.51) is better than 88.17% of its industry peers.
A Debt/Equity ratio of 3.43 is on the high side and indicates that COLL has dependencies on debt financing.
The Debt to Equity ratio of COLL (3.43) is worse than 84.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | 4.51 | ||
| Altman-Z | 1.02 |
ROIC/WACC1.07
WACC9.75%
2.3 Liquidity
COLL has a Current Ratio of 0.97. This is a bad value and indicates that COLL is not financially healthy enough and could expect problems in meeting its short term obligations.
COLL's Current ratio of 0.97 is on the low side compared to the rest of the industry. COLL is outperformed by 86.56% of its industry peers.
A Quick Ratio of 0.88 indicates that COLL may have some problems paying its short term obligations.
COLL has a Quick ratio of 0.88. This is amonst the worse of the industry: COLL underperforms 83.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 3566.67%, which is quite impressive.
Measured over the past years, COLL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.79% on average per year.
COLL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.63%.
Measured over the past years, COLL shows a quite strong growth in Revenue. The Revenue has been growing by 15.11% on average per year.
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5YN/A
EPS Q2Q%203.77%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y15.11%
Sales Q2Q%16.52%
3.2 Future
Based on estimates for the next years, COLL will show a very strong growth in Earnings Per Share. The EPS will grow by 46.17% on average per year.
The Revenue is expected to grow by 3.66% on average over the next years.
EPS Next Y434.25%
EPS Next 2Y139.53%
EPS Next 3Y84.71%
EPS Next 5Y46.17%
Revenue Next Year11.41%
Revenue Next 2Y14.72%
Revenue Next 3Y10.86%
Revenue Next 5Y3.66%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.62, the valuation of COLL can be described as very cheap.
Based on the Price/Earnings ratio, COLL is valued cheaply inside the industry as 97.31% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.47, COLL is valued rather cheaply.
The Price/Forward Earnings ratio is 4.57, which indicates a rather cheap valuation of COLL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.24% of the companies listed in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.62 | ||
| Fwd PE | 4.57 |
4.2 Price Multiples
COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 96.24% of the companies in the same industry.
COLL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. COLL is cheaper than 97.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.18 | ||
| EV/EBITDA | 4.87 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of COLL may justify a higher PE ratio.
A more expensive valuation may be justified as COLL's earnings are expected to grow with 84.71% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y139.53%
EPS Next 3Y84.71%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COLLEGIUM PHARMACEUTICAL INC
NASDAQ:COLL (2/4/2025, 8:00:00 PM)
After market: 30.93 0 (0%)30.93
-0.27 (-0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners126.05%
Inst Owner Change-2.66%
Ins Owners0.82%
Ins Owner Change1.28%
Market Cap997.49M
Analysts80
Price Target43.86 (41.8%)
Short Float %17.7%
Short Ratio12.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.03%
Min EPS beat(2)-0.88%
Max EPS beat(2)6.95%
EPS beat(4)3
Avg EPS beat(4)19.84%
Min EPS beat(4)-0.88%
Max EPS beat(4)51.47%
EPS beat(8)5
Avg EPS beat(8)-25.67%
EPS beat(12)6
Avg EPS beat(12)-31.34%
EPS beat(16)6
Avg EPS beat(16)-34.48%
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-3.25%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.96%
Revenue beat(12)5
Avg Revenue beat(12)-5.91%
Revenue beat(16)6
Avg Revenue beat(16)-5.15%
PT rev (1m)1.78%
PT rev (3m)-0.58%
EPS NQ rev (1m)2.16%
EPS NQ rev (3m)-12.68%
EPS NY rev (1m)0.28%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)19.36%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.62 | ||
| Fwd PE | 4.57 | ||
| P/S | 1.66 | ||
| P/FCF | 5.18 | ||
| P/OCF | 5.15 | ||
| P/B | 4.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.87 |
EPS(TTM)5.5
EY17.78%
EPS(NY)6.77
Fwd EY21.89%
FCF(TTM)5.97
FCFY19.29%
OCF(TTM)6.01
OCFY19.42%
SpS18.58
BVpS7.26
TBVpS-26.62
PEG (NY)0.01
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROCE | 16.46% | ||
| ROIC | 10.46% | ||
| ROICexc | 11.65% | ||
| ROICexgc | N/A | ||
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% | ||
| FCFM | 32.11% |
ROA(3y)4.14%
ROA(5y)1.83%
ROE(3y)15.68%
ROE(5y)7.1%
ROIC(3y)8.7%
ROIC(5y)N/A
ROICexc(3y)14.87%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.69%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y24.23%
ROICexc growth 5YN/A
OM growth 3Y19.53%
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y7.07%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | 4.51 | ||
| Debt/EBITDA | 2.35 | ||
| Cap/Depr | 0.84% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 3.08 | ||
| Cash Conversion | 56.69% | ||
| Profit Quality | 217.22% | ||
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1.02 |
F-Score6
WACC9.75%
ROIC/WACC1.07
Cap/Depr(3y)143.52%
Cap/Depr(5y)215.73%
Cap/Sales(3y)41.48%
Cap/Sales(5y)49.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5YN/A
EPS Q2Q%203.77%
EPS Next Y434.25%
EPS Next 2Y139.53%
EPS Next 3Y84.71%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y15.11%
Sales Q2Q%16.52%
Revenue Next Year11.41%
Revenue Next 2Y14.72%
Revenue Next 3Y10.86%
Revenue Next 5Y3.66%
EBIT growth 1Y48.37%
EBIT growth 3Y46.16%
EBIT growth 5YN/A
EBIT Next Year153.16%
EBIT Next 3Y42.12%
EBIT Next 5Y17.89%
FCF growth 1Y140.16%
FCF growth 3YN/A
FCF growth 5Y13.6%
OCF growth 1Y105.83%
OCF growth 3Y43.03%
OCF growth 5Y10.16%